Dr. William K. Oh Appointed Founding Chair; Drs. Roy S. Herbst, Ranjit S. Bindra and Rajwanth Veluswamy join as Inaugural Members CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Archetype ...

AGM/EGMMedios AG Annual General Meeting 2025: Shareholders approve all proposed resolutions 27.05.2025 / 16:06 CET/CESTThe issuer is solely responsible for the content of this announcement.Press ...

Half Year Report/Half Year ResultsMeVis publishes figures for the first half of fiscal year 2024/2025 27.05.2025 / 15:45 CET/CESTThe issuer is solely responsible for the content of this ...

Ambience's latest AI model reduces coding errors and targets $266 billion in annual administrative waste SAN FRANCISCO, CA / ACCESS Newswire / May 27, 2025 / Ambience Healthcare today announced a ...

Selvita is the first contract research organisation (CRO) to license a Chemical Protein Stability Assay developed and ...

Market LaunchFormycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada 27.05.2025 / 14:30 CET/CESTThe issuer is solely responsible for ...

Dr. Daniel Becker presented advanced rhinoplasty techniques at The EAFPS 47th Annual Conference in Istanbul. VOORHEES, NEW JERSEY / ACCESS Newswire / May 27, 2025 / Becker Rhinoplasty Center is ...

Structured Equity Raise Positions the Company for Accelerated Future Growth and Provides Liquidity for Existing Shareholders PENSACOLA, FLORIDA / ACCESS Newswire / May 27, 2025 / Emergency Care ...

Challenges, Innovations, and Hope for the FutureClinical trials are the foundation of modern medicine, guiding the ...

The Hidden Language of GlycansImagine a vast molecular conversation happening within and between cells—where sugar-based structures act as sophisticated messengers carrying critical biological ...

The company developing what could be the first oral treatment to tackle the tau protein pathology of Alzheimer's disease has announced the appointment of a leading industry figure to its board.Dr ...

Further Validates CryptigensTM as Actionable Targets for Cancer Immunotherapy Montreal, Quebec, & Cambridge, UK, 27 May 2025 – Epitopea, a transatlantic cancer immunotherapy company, and Institute for ...